What is first-trimester combined screening?
First-trimester combined screening is a screening test that combines a nuchal translucency (NT) ultrasound with a blood test to estimate the chance that your baby has certain chromosomal conditions, most commonly Down syndrome (trisomy 21) and trisomy 18. It measures the thickness of a small, fluid-filled space at the back of baby's neck, combines that with two protein and hormone levels from your blood — PAPP-A and hCG — and factors in your age to produce a personalized risk estimate. It's offered, not required, as part of routine prenatal care, usually around the time of your first-trimester dating ultrasound.
It's worth being clear about what this test is and isn't from the start. It doesn't diagnose anything — it estimates chance, expressed as something like "1 in 1,200" or "1 in 60." A higher-chance result means further testing is worth considering, not that anything is confirmed to be wrong. Plenty of people who get a higher-chance result go on to have a baby without the condition that was flagged, and diagnostic testing is the only way to know for certain either way.
When is combined screening done?
Combined screening happens in a narrow window — typically between 11 weeks and 13 weeks 6 days of pregnancy. This timing isn't arbitrary: the nuchal translucency measurement is only reliable within this range, because baby is large enough to measure clearly but hasn't yet grown past the point where that neck-fold measurement naturally changes. If your dates put you earlier or later than this window when you arrive for the scan, your provider may reschedule it or move you to a different screening option that fits your stage of pregnancy instead.
The blood draw for PAPP-A and hCG can sometimes happen slightly earlier than the ultrasound, often from around 9 to 13 weeks, with both results combined once they're both in. Some clinics do the blood draw and the ultrasound at the same visit; others split them across two appointments a week or so apart. Either way, your final combined result isn't calculated until both pieces of information are available, so don't expect a number back the same day as the blood draw on its own.
What does the test actually measure?
The ultrasound part measures nuchal translucency — the thickness of a small, normal, fluid-filled space at the back of baby's neck that every baby has at this stage of development. A thicker-than-typical measurement is associated with a higher chance of certain chromosomal conditions and some heart defects, though many babies with a thicker NT measurement turn out to be entirely unaffected. The blood test measures two substances your body naturally produces during pregnancy — PAPP-A, a protein, and hCG, a hormone — both of which tend to run higher or lower than typical when certain chromosomal conditions are present.
None of these three numbers — NT, PAPP-A, hCG — means much read on its own. A specialized calculation combines all three with your age, and sometimes your weight and ethnicity, to produce one overall risk figure. That's why it's called a "combined" screen: no single measurement drives the outcome, and an unusual value in one component can be balanced out or reinforced by the other two. Your provider or a genetic counselor can walk you through exactly what each part of your individual result showed.
What does a result actually tell you?
Your result comes back as a probability, not a yes-or-no answer, usually sorted into "lower-chance" or "higher-chance" categories based on a threshold your lab sets. A lower-chance result is reassuring but doesn't rule out every possibility — screening tests are designed to flag pregnancies worth a closer look, not to catch every single case. A higher-chance result means your specific probability crossed the threshold the lab uses, which opens the door to further testing if you want it — on its own, it is not a diagnosis.
It can help to think of the result as a starting risk that gets adjusted by new information, rather than a verdict. Someone who started with a low age-related chance can still land in the "higher-chance" group if the ultrasound or blood values were unusual, and someone with an older age-related starting point can land in "lower-chance" if the rest of the results look typical. Neither outcome tells you exactly what's happening in this specific pregnancy — only further testing, like NIPT or a diagnostic procedure, can do that.
How does combined screening compare to other options?
Combined screening is one of several ways to screen for chromosomal conditions in early pregnancy, sitting between simple age-based risk and more sensitive blood-only testing. NIPT (non-invasive prenatal testing), a blood test that analyzes fragments of placental DNA circulating in your blood, generally detects a higher proportion of affected pregnancies than combined screening and can be done from around 9 to 10 weeks. Diagnostic tests — CVS and amniocentesis — are the only tests that give a definitive answer, but they carry a small procedure-related risk of pregnancy loss that screening tests don't carry.
Which option makes sense depends on your priorities, your insurance coverage, and what your provider offers locally. Combined screening is often more widely available and less expensive than NIPT, even though NIPT tends to be more sensitive at detecting the conditions it screens for. Some people choose combined screening because it also gives useful information about the pregnancy's ultrasound appearance at this stage; others go straight to NIPT for its higher detection rate. This is exactly the kind of decision worth talking through with your midwife, doctor, or a genetic counselor rather than deciding from an article alone.
What happens if your results come back higher-chance?
A higher-chance result typically leads to a conversation about next steps, not an immediate procedure. Common next steps include NIPT, which can refine the risk further without any procedural risk to the pregnancy, genetic counseling to talk through what the specific numbers mean, or a diagnostic test like CVS or amniocentesis if you want a definitive answer. There's no single required path — what you choose depends on how much certainty you want, how you'd use the information, and your own comfort with the small risks diagnostic testing carries.
It's worth saying plainly: most people who get a higher-chance result go on to find, through further testing, that their baby does not have the condition that was flagged. That doesn't erase the anxiety of getting that call, and it's entirely reasonable to feel shaken even by a statistic that's ultimately in your favor. Genetic counselors are trained specifically to help with this — both the numbers and the emotional weight behind them — and asking to speak with one is a normal, expected step, not an overreaction.
Is combined screening required, and can you decline it?
No — combined screening, like all prenatal genetic screening, is entirely optional. Your provider should offer it and explain what it involves, but the decision to have it, decline it, or choose a different path, such as NIPT alone or no chromosomal screening at all, is yours to make. Some people want as much information as early as possible; others prefer to wait for the anatomy scan, and some decline this kind of screening altogether and address anything that comes up later. None of these approaches is wrong.
If you're unsure, it can help to ask yourself what you'd actually do with a higher-chance result before you have the test. Some people would pursue diagnostic testing right away, some would mainly want to prepare emotionally, and some would decline further testing no matter what the result showed. There's no obligation to test simply because it's offered, and no single path is more responsible than another. Your provider can help you think through what genuinely fits your situation and your preferences.